Laser-assisted topical drug delivery by using a low-fluence fractional laser

Imiquimod and macromolecules

Woan Ruoh Lee, Shing Chuan Shen, Saleh A. Al-Suwayeh, Hung Hsu Yang, Cheng Yin Yuan, Jia You Fang

Research output: Contribution to journalArticle

81 Citations (Scopus)

Abstract

The aim of this study was to evaluate the ability of a low-fluence fractional erbium:yttrim-aluminum-garnet (Er:YAG) laser, with a wavelength of 2940 nm, for enhancing and controlling the skin permeation of imiquimod and macromolecules such as polypeptides and fluorescein isothiocyanate (FITC)-labeled dextran (FD). The in vitro permeation has been determined using a Franz diffusion cell, with porcine skin and nude mouse skin as the barriers. Hyperproliferative and ultraviolet (UV)-irradiated skins were also used as barrier models to mimic the clinical therapeutic conditions. Confocal laser scanning microscopy (CLSM) was used to examine the in vivo nude mouse skin uptake of peptide, FITC, and FD. Both in vitro and in vivo results indicated an improvement in permeant skin delivery by the laser. The laser fluence and number of passes were found to play important roles in controlling drug transport. Increases of 46- and 127-fold in imiquimod flux were detected using the respective fluences of 2 and 3 J/cm 2 with 4 pulses. An imiquimod concentration of 0.4% from aqueous vehicle with laser treatment was sufficient to approximate the flux from the commercial cream with an imiquimod dose of 5% without laser treatment, indicating a reduction of the drug dose by 125-fold. The enhancement of peptide permeation was size and sequence dependent, with the smaller molecular weight (MW) and more-hydrophilic entities showing greater enhancing effect. Skin permeation of FD with an MW of at least 150 kDa could be achieved with fractional laser irradiation. CLSM images revealed intense green fluorescence from the permeants after exposure of the skin to the laser. The follicular pathway was significant in laser-assisted permeation.

Original languageEnglish
Pages (from-to)240-248
Number of pages9
JournalJournal of Controlled Release
Volume153
Issue number3
DOIs
Publication statusPublished - Aug 10 2011

Fingerprint

imiquimod
Lasers
Skin
Pharmaceutical Preparations
Nude Mice
Confocal Microscopy
Peptides
Molecular Weight
Erbium
Fluorescein
Aluminum
Swine
Fluorescence

Keywords

  • Fractional laser
  • Imiquimod
  • Macromolecules
  • Peptides
  • Skin permeation

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Laser-assisted topical drug delivery by using a low-fluence fractional laser : Imiquimod and macromolecules. / Lee, Woan Ruoh; Shen, Shing Chuan; Al-Suwayeh, Saleh A.; Yang, Hung Hsu; Yuan, Cheng Yin; Fang, Jia You.

In: Journal of Controlled Release, Vol. 153, No. 3, 10.08.2011, p. 240-248.

Research output: Contribution to journalArticle

Lee, Woan Ruoh ; Shen, Shing Chuan ; Al-Suwayeh, Saleh A. ; Yang, Hung Hsu ; Yuan, Cheng Yin ; Fang, Jia You. / Laser-assisted topical drug delivery by using a low-fluence fractional laser : Imiquimod and macromolecules. In: Journal of Controlled Release. 2011 ; Vol. 153, No. 3. pp. 240-248.
@article{94115deb5d5748fab3ce03c62e69acfb,
title = "Laser-assisted topical drug delivery by using a low-fluence fractional laser: Imiquimod and macromolecules",
abstract = "The aim of this study was to evaluate the ability of a low-fluence fractional erbium:yttrim-aluminum-garnet (Er:YAG) laser, with a wavelength of 2940 nm, for enhancing and controlling the skin permeation of imiquimod and macromolecules such as polypeptides and fluorescein isothiocyanate (FITC)-labeled dextran (FD). The in vitro permeation has been determined using a Franz diffusion cell, with porcine skin and nude mouse skin as the barriers. Hyperproliferative and ultraviolet (UV)-irradiated skins were also used as barrier models to mimic the clinical therapeutic conditions. Confocal laser scanning microscopy (CLSM) was used to examine the in vivo nude mouse skin uptake of peptide, FITC, and FD. Both in vitro and in vivo results indicated an improvement in permeant skin delivery by the laser. The laser fluence and number of passes were found to play important roles in controlling drug transport. Increases of 46- and 127-fold in imiquimod flux were detected using the respective fluences of 2 and 3 J/cm 2 with 4 pulses. An imiquimod concentration of 0.4{\%} from aqueous vehicle with laser treatment was sufficient to approximate the flux from the commercial cream with an imiquimod dose of 5{\%} without laser treatment, indicating a reduction of the drug dose by 125-fold. The enhancement of peptide permeation was size and sequence dependent, with the smaller molecular weight (MW) and more-hydrophilic entities showing greater enhancing effect. Skin permeation of FD with an MW of at least 150 kDa could be achieved with fractional laser irradiation. CLSM images revealed intense green fluorescence from the permeants after exposure of the skin to the laser. The follicular pathway was significant in laser-assisted permeation.",
keywords = "Fractional laser, Imiquimod, Macromolecules, Peptides, Skin permeation",
author = "Lee, {Woan Ruoh} and Shen, {Shing Chuan} and Al-Suwayeh, {Saleh A.} and Yang, {Hung Hsu} and Yuan, {Cheng Yin} and Fang, {Jia You}",
year = "2011",
month = "8",
day = "10",
doi = "10.1016/j.jconrel.2011.03.015",
language = "English",
volume = "153",
pages = "240--248",
journal = "Journal of Controlled Release",
issn = "0168-3659",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Laser-assisted topical drug delivery by using a low-fluence fractional laser

T2 - Imiquimod and macromolecules

AU - Lee, Woan Ruoh

AU - Shen, Shing Chuan

AU - Al-Suwayeh, Saleh A.

AU - Yang, Hung Hsu

AU - Yuan, Cheng Yin

AU - Fang, Jia You

PY - 2011/8/10

Y1 - 2011/8/10

N2 - The aim of this study was to evaluate the ability of a low-fluence fractional erbium:yttrim-aluminum-garnet (Er:YAG) laser, with a wavelength of 2940 nm, for enhancing and controlling the skin permeation of imiquimod and macromolecules such as polypeptides and fluorescein isothiocyanate (FITC)-labeled dextran (FD). The in vitro permeation has been determined using a Franz diffusion cell, with porcine skin and nude mouse skin as the barriers. Hyperproliferative and ultraviolet (UV)-irradiated skins were also used as barrier models to mimic the clinical therapeutic conditions. Confocal laser scanning microscopy (CLSM) was used to examine the in vivo nude mouse skin uptake of peptide, FITC, and FD. Both in vitro and in vivo results indicated an improvement in permeant skin delivery by the laser. The laser fluence and number of passes were found to play important roles in controlling drug transport. Increases of 46- and 127-fold in imiquimod flux were detected using the respective fluences of 2 and 3 J/cm 2 with 4 pulses. An imiquimod concentration of 0.4% from aqueous vehicle with laser treatment was sufficient to approximate the flux from the commercial cream with an imiquimod dose of 5% without laser treatment, indicating a reduction of the drug dose by 125-fold. The enhancement of peptide permeation was size and sequence dependent, with the smaller molecular weight (MW) and more-hydrophilic entities showing greater enhancing effect. Skin permeation of FD with an MW of at least 150 kDa could be achieved with fractional laser irradiation. CLSM images revealed intense green fluorescence from the permeants after exposure of the skin to the laser. The follicular pathway was significant in laser-assisted permeation.

AB - The aim of this study was to evaluate the ability of a low-fluence fractional erbium:yttrim-aluminum-garnet (Er:YAG) laser, with a wavelength of 2940 nm, for enhancing and controlling the skin permeation of imiquimod and macromolecules such as polypeptides and fluorescein isothiocyanate (FITC)-labeled dextran (FD). The in vitro permeation has been determined using a Franz diffusion cell, with porcine skin and nude mouse skin as the barriers. Hyperproliferative and ultraviolet (UV)-irradiated skins were also used as barrier models to mimic the clinical therapeutic conditions. Confocal laser scanning microscopy (CLSM) was used to examine the in vivo nude mouse skin uptake of peptide, FITC, and FD. Both in vitro and in vivo results indicated an improvement in permeant skin delivery by the laser. The laser fluence and number of passes were found to play important roles in controlling drug transport. Increases of 46- and 127-fold in imiquimod flux were detected using the respective fluences of 2 and 3 J/cm 2 with 4 pulses. An imiquimod concentration of 0.4% from aqueous vehicle with laser treatment was sufficient to approximate the flux from the commercial cream with an imiquimod dose of 5% without laser treatment, indicating a reduction of the drug dose by 125-fold. The enhancement of peptide permeation was size and sequence dependent, with the smaller molecular weight (MW) and more-hydrophilic entities showing greater enhancing effect. Skin permeation of FD with an MW of at least 150 kDa could be achieved with fractional laser irradiation. CLSM images revealed intense green fluorescence from the permeants after exposure of the skin to the laser. The follicular pathway was significant in laser-assisted permeation.

KW - Fractional laser

KW - Imiquimod

KW - Macromolecules

KW - Peptides

KW - Skin permeation

UR - http://www.scopus.com/inward/record.url?scp=79960930858&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960930858&partnerID=8YFLogxK

U2 - 10.1016/j.jconrel.2011.03.015

DO - 10.1016/j.jconrel.2011.03.015

M3 - Article

VL - 153

SP - 240

EP - 248

JO - Journal of Controlled Release

JF - Journal of Controlled Release

SN - 0168-3659

IS - 3

ER -